Cleared Traditional

K211375 - Blazer Dx-20 Bidirectional Steerable Di...

K211375 is the FDA 510(k) clearance for Blazer Dx-20 Bidirectional Steerable Di... by Boston Scientific Corporation. It is a Class 2 Cardiovascular device (product code DRF) cleared through the Traditional 510(k) pathway after a 129-day FDA review.

K211375 · Boston Scientific Corporation · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2021
Decision
129d
Days
Class 2
Risk

K211375 is an FDA 510(k) clearance for the Blazer™ Dx-20 Bidirectional Steerable Diagnostic Catheter. Classified as Catheter, Electrode Recording, Or Probe, Electrode Recording (product code DRF), Class II - Special Controls.

Submitted by Boston Scientific Corporation (St Paul, US). The FDA issued a Cleared decision on September 10, 2021 after a review of 129 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1220 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Boston Scientific Corporation devices

Submission Details

510(k) Number K211375 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 04, 2021
Decision Date September 10, 2021
Days to Decision 129 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
4d slower than avg
Panel avg: 125d · This submission: 129d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DRF Catheter, Electrode Recording, Or Probe, Electrode Recording
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1220
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRF Catheter, Electrode Recording, Or Probe, Electrode Recording

All 97
Devices cleared under the same product code (DRF) and FDA review panel - the closest regulatory comparables to K211375.
LASSOSTAR NAV Circular Mapping Catheter
K211219 · Biosense Webster, Inc. · Jan 2022
ViaCath, AcQRate Dx Steerable Catheter
K212593 · Biotronick, Inc. · Oct 2021
Polaris X Unidirectional Steerable Diagnostic Catheter
K211494 · Boston Scientific Corporation · Sep 2021
MultiCath, AcQRate Dx Fixed Curve Catheter
K201445 · Biotronik, Inc. · Sep 2021
Reprocessed Inquiry Steerable Diagnostic EP Catheter
K203261 · Innovative Health, LLC · Mar 2021
LassoStar Circular Mapping Catheter
K193632 · Biosense Webster, Inc. · Jun 2020